Investing Profile

Jim Scopa

VC
Photo of Jim Scopa, Managing Partner at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
418 CONNECTIONS
Stanford University Network
92 CONNECTIONS
Bain & Company Network
92 CONNECTIONS
Harvard Law School Network
34 CONNECTIONS
Harvard College Network
29 CONNECTIONS
cb
MPM Capital Managing Partner
10
$100M
CompanyStageDateRound SizeTotal Raised
TriVascular
Series ENov 2013$40M
Series DJun 2012$60M
Series CAug 2010$60M
Series BNov 2009$30M
Series AMar 2008$65M
$260M
Co-investors: Jake Nunn (SR One Capital Management)
iPierian
Series UnknownSep 2013$30M
Series BNov 2010$29M
Series UnknownJul 2009$12M
$71M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Beth Seidenberg (Westlake Village BioPartners), Wesley Chan (FPV Fund), Rajeev Dadoo (SR One)
Astute Medical
Series CJun 2012$40M
$80M
Co-investors: James Blair (Domain Associates)
Conatus Pharmaceuticals
Series BApr 2011$8M
$50M
Co-investors: Paul Klingenstein (Aberdare Ventures), Shahzad Malik (Advent Life Sciences)
Fellow, Distinguished Careers Institute ("DCI") Stanford University2017 - Present
Managing Director -- Member of Investment Committee MPM Capital2005 - 2017
Partner and Managing Director Thomas Weisel Partners LLC2002 - 2005
Managing Director Deutsche Bank/Alex. Brown & Sons1990 - 2002
Associate Investment Banking Salomon Brothers Inc1986 - 1989
Associate Consultant Bain & Company1980 - 1982
Harvard Business School MBA Industry and Competitive Analysis, Finance
Harvard Law School J.D. Securities Law, Corporate Finance and Tax, Member of the California bar (inactive)
Harvard College A.B. History and Science (Biology)
Framingham North H.S.